Ok Biotech Co Ltd (4155) - Total Liabilities

Latest as of December 2025: NT$1.27 Billion TWD ≈ $40.12 Million USD

Based on the latest financial reports, Ok Biotech Co Ltd (4155) has total liabilities worth NT$1.27 Billion TWD (≈ $40.12 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ok Biotech Co Ltd - Total Liabilities Trend (2009–2025)

This chart illustrates how Ok Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Ok Biotech Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Ok Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Ok Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Engenco Ltd AU:EGN	Australia	AU$94.56 Million
Loulis Mills S.A. AT:KYLO	Greece	€125.32 Million
Gray Television Inc NYSE:GTN-A	USA	$7.56 Billion
TECO Image Systems Co Ltd TWO:5438	Taiwan	NT$780.96 Million
Golan Plastic TA:GLPL	Israel	ILA195.87 Million
Ramssol Group Bhd KLSE:0236	Malaysia	RM52.71 Million
De Poan Pneumatic TWO:1570	Taiwan	NT$105.16 Million
China Fineblanking Technology Co Ltd TWO:1586	Taiwan	NT$1.87 Billion

Liability Composition Analysis (2009–2025)

This chart breaks down Ok Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4155 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.51	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ok Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ok Biotech Co Ltd (2009–2025)

The table below shows the annual total liabilities of Ok Biotech Co Ltd from 2009 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$1.27 Billion ≈ $40.12 Million	+12.84%
2024-12-31	NT$1.13 Billion ≈ $35.55 Million	+67.85%
2023-12-31	NT$672.26 Million ≈ $21.18 Million	-44.66%
2022-12-31	NT$1.21 Billion ≈ $38.27 Million	+9.47%
2021-12-31	NT$1.11 Billion ≈ $34.96 Million	+39.43%
2020-12-31	NT$795.91 Million ≈ $25.08 Million	-13.34%
2019-12-31	NT$918.40 Million ≈ $28.93 Million	+57.60%
2018-12-31	NT$582.73 Million ≈ $18.36 Million	-14.06%
2017-12-31	NT$678.07 Million ≈ $21.36 Million	+23.14%
2016-12-31	NT$550.64 Million ≈ $17.35 Million	+11.16%
2015-12-31	NT$495.36 Million ≈ $15.61 Million	-11.72%
2014-12-31	NT$561.11 Million ≈ $17.68 Million	-33.75%
2013-12-31	NT$847.00 Million ≈ $26.69 Million	+160.10%
2012-12-31	NT$325.65 Million ≈ $10.26 Million	+77.65%
2011-12-31	NT$183.31 Million ≈ $5.78 Million	+93.76%
2010-12-31	NT$94.60 Million ≈ $2.98 Million	+13.41%
2009-12-31	NT$83.42 Million ≈ $2.63 Million	--

About Ok Biotech Co Ltd

TW:4155 Taiwan Medical Devices

Market Cap

$68.03 Million

NT$2.16 Billion TWD

Market Cap Rank

#20780 Global

#1272 in Taiwan

Share Price

NT$15.30

Change (1 day)

+0.00%

52-Week Range

NT$12.90 - NT$16.85

All Time High

NT$37.98